GrantRover ↗

← All opportunities

National Institutes of Health · United States

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in… (PATC3H-IN)

Full title in the source: Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

Forecast — expected to open 24 Jul 2027

This is a forecast: the funder has announced the opportunity but it is not open yet; posting is expected around 24 Jul 2027 and the estimated deadline is 28 Oct 2027. Eligible applicant types include native American tribal organizations (other than Federally recognized tribal governments), nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, private institutions of higher education and 12 more.

Deadline
Estimated 28 Oct 2027 (not yet confirmed)
Opens
24 Jul 2027
Grant amount
Not stated — see the official call
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Cost sharing
Not required
Likely applicant types
Public bodies, Non-profits, Universities & research, SMEs / start-ups, Companies From source categories or programme rules; the call decides.
Funder
National Institutes of Health
Reference
RFA-HD-28-002
Assistance listing
93.865 Child Health and Human Development Extramural Research
Last checked
15 Nov 2026

Open the official call ↗

About this call

The Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings–Implementation Science Network (PATC3H-IN) conducts implementation science (IS) research on adolescent HIV. PATC3H-IN develops scalable, low-resource care delivery models in low- and middle-income countries that can be adapted for marginalized and high-burden US populations. It aligns with NIH's Unified Strategy prioritizing IS to expand uptake of and access to HIV interventions. PATC3H-IN will study and test the impact of implementation strategies on adolescent HIV incidence, prevention uptake, and viral suppression, providing a strong evidence base for interventions that can be used in US-based programs.

Resource-constrained, high-burden settings outside the US provide an unparalleled environment for adolescent HIV implementation science that aims to strengthen HIV care in the US. Higher HIV incidence and prevalence allow researchers to rigorously evaluate implementation strategies in large adolescent populations. The studies produce robust evidence on effectiveness, scalability, adaptation, and sustainability. These studies complement U.S.-based research by generating evidence that is difficult to obtain within the smaller, geographically dispersed population of adolescents living with HIV in the US. In addition, they test implementation strategies across a wide range of health systems and community settings.

Read the full text

Limited local resources outside the US also drive innovation through necessity. Health systems develop efficient, scalable models of care–including differentiated service delivery, task sharing, peer support, digital adherence interventions, and community-based care–to maximize impact with available resources. Many international HIV programs also operate within coordinated care systems that can rapidly test, adapt, and refine service delivery strategies through continuous, data-driven evaluation. This operational flexibility supports rapid-cycle learning and implementation at a pace that is often difficult to achieve in the more complex and decentralized U.S. healthcare system. Combined with access to large adolescent cohorts, these settings provide an exceptional platform for generating rigorous, practice-ready implementation evidence.

The innovations are directly relevant to the United States, where adolescents and young adults living with HIV are projected to incur nearly $17 billion in lifetime healthcare costs, averaging approximately $685,000 per person. Despite advances in HIV prevention and treatment, nearly 39,000 people receive new HIV diagnoses each year in the United States. About one in five of these new cases occur among adolescents and young adults, and many individuals still receive their diagnosis at later stages of infection. Many U.S. adolescents affected by HIV face the same barriers as youth in resource-constrained settings, including poverty, housing instability, stigma, transportation challenges, workforce shortages, and fragmented care. As a result, implementation strategies that succeed in resource-constrained settings can help build more resilient and scalable models of care in the US. Global adolescent HIV implementation research provides critical evidence needed to achieve the goals of the Ending the HIV Epidemic in the U.S. initiative by accelerating the translation of effective, resilient, and cost-conscious models of care into domestic practice.

Adolescents and young people represent a growing share of people living with HIV in the US and worldwide. Comprising Clinical Research Centers and a Data and Coordinating Center, PATC3H-IN addresses this gap by supporting IS research to prevent HIV acquisition among at-risk adolescents and improve care outcomes for youth living with HIV. Grant authorities allowing the Eunice Kennedy Shriver National Institute of Child Health and Human Development to forecast this opportunity include: 42 U.S.C. 281 (Sec. 401); 42 U.S.C.…

Who can apply

Applicant categories are a starting point. The official call decides eligibility.

Topics

Health

How to apply

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Contact

Maternal and Pediatric Infectious Diseases Branch (MPIDB) · nichd_mpidb_nofos@mail.nih.gov · Please contact via e-mail

Where these facts come from

FactValueHow we knowTaken from the source
Deadline28 October 2027official data field15 Nov 2026
Amount per applicantUnknown — not stated in the source we holdunknown—
Total budgetUnknown — not stated in the source we holdunknown—
Funding rateNo mandatory cost sharing stated; funding percentage not statedread from the official text15 Nov 2026
Who can applyNative American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions…official data field15 Nov 2026
Where to applyUnknown — not stated in the source we holdunknown—

Official sources

Official call page

Facts on this page come from the funder’s official data, taken on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.

More from National Institutes of Health

National Institutes of Health United States

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… (R34 Clinical Trial Required)

PAR-25-274

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…

National Institutes of Health United States

Investigator Initiated Clinical Trials of Complementary and Integrative… (R01 Clinical Trial Required)

PAR-25-268

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…

National Institutes of Health United States

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…